Advertisement

Picture Sino Biological Symposium Antibody Engineering Leipzig 650x100px
Document › Details

AH Diagnostics A/S. (4/3/23). "Press Release: Helle Zacho Becomes the New CEO of the AH Diagnostics Group".

Organisations Organisation AH Diagnostics A/S (DK)
  Group Dutscher (DD) (Group)
  Organisation 2 Novo Nordisk A/S
  Group Novo Group (Group)
Products Product diagnostics (medical/biological)
  Product 2 reagents (bio/biochemical)
Persons Person Zacho, Helle (Dutscher 202304– CEO of AH Diagnostics joined as CSO in 2017 before Novo Nordisk)
  Person 2 Rüdiger, Niels S. (AH Diagnostics 202304– Board Chair + CVO for Business Development before CEO)
     


The AH diagnostics Group announces new CEO Helle Zacho, starting on April 1, 2023. The current CEO, Niels S. Rüdiger, will step down from the role after almost 22 years and take over as CVO for business development of the product portfolio and as Chairman of the Board of the company’s enterprises.

The management change has been planned since Helle Zacho joined as CSO in AH diagnostics so that Helle can focus more dedicated on commercial business development. Customers and partners can still expect a high level of innovation and knowledge, but with even greater attention to ensuring a good customer experience and a strong relationship.

"I have seen the opportunity to prioritize and do what I do best and find most rewarding, namely, to be able to focus on business development and use of my international network, which I have built up over the last +20 years in the industry. Helle Zacho has very good leadership qualities, and in the spirit of the company knows how to communicate all messages to our good employees. As CEO, Helle Zacho gets the opportunity to focus on the whole of the company – and I have great confidence in her and the future she can create in AH diagnostics." – Niels S. Rüdiger, CVO and Chairman of the Board.

Helle Zacho joined the company in 2017 as CSO, and during this period she has focused on creating a strong framework around the sales organization, marketing, and customer experience. Maintaining close cooperation between the two is a natural transition, as it helps to ensure the strategic initiatives the company is working with. Helle has a commercial background as a former Sales Director at Novo Nordisk and a Master of Business Administration from Aarhus University.

"My ambition is to continue the high level we are known for in AH diagnostics. Some of the areas we will prioritize in particular are helping customers make the most sustainable choices and ensuring continued high customer satisfaction. I look forward to taking on the new role and I hope to create an even better workplace for our employees and be a valued partner for our customers and suppliers." – Helle Zacho, CEO.

AH diagnostics was founded in 1986 in Aarhus and is today a Nordic distributor of equipment and reagents for most laboratories within Life Science, diagnostics, biotech, and pharma. With 5 offices in 4 Nordic countries, the company has approximately 50 employees. Niels S. Rüdiger took over as CEO in 2001 and continuously took ownership of the company to 80%. In 2021, AH diagnostics was acquired by the French Dutscher Group, which today includes distribution companies in almost all European countries.


Media contact:

Niels S. Rüdiger
CVO AH diagnostics AS
+45 8745 9010
www.ahdiagnostics.com

Helle Zacho
CEO AH diagnostics AS
+45 8745 9010
www.ahdiagnostics.com

   
Record changed: 2024-01-20

Advertisement

Picture Berlin Partner Top News Captain T Cell Therapies 650x200px

More documents for Dutscher (DD) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Sino Biological Symposium Antibody Engineering Leipzig 650x200px




» top